Vertex Pharmaceuticals Incorporated is an American biopharmaceutical company based in Boston, Massachusetts. It was one of the first biotech firms to use an explicit strategy of rational drug design rather than combinatorial chemistry. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Vertex Pharmaceuticals (United States), United States, covering academic research published from 2000 to 2023. Read More.
Open Access Percentage
46%
Total
Publications
1.8K
Total Open
Publications
818
Total
Citations
103K
Open Access
Percentage
46%
Total
Publications
1.8K
Total Open
Publications
818
Total
Citations
103K
Breakdown
Publisher Open
17%
Both
19%
Other Platform Open
10%
Closed
54%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 25%
158
Hybrid 38%
243
No Guarantees 37%
237
Other Platform Open
Domain 81%
413
Institution 32%
161
Preprint 11%
56
Other Internet 8%
42
Public 7%
34
Other Platform Locations
Name | Platform Type | Publications |
---|---|---|
PubMed Central | Domain | 411 |
Europe PMC | Domain | 278 |
DOI | Other Internet | 49 |
Semantic Scholar | Public | 27 |
bioRxiv | Preprint | 26 |
Research Square | Preprint | 19 |
University of Oxford - Oxford University Research Archive (ORA) | Institution | 16 |
University College London - UCL Discovery | Institution | 13 |
University of California - eScholarship University of California | Institution | 12 |
Queen's University Belfast - Research Portal | Institution | 12 |